Last reviewed · How we verify
NCT04733859
Using Red Djulis Products Can Improve Skin Conditions
NA trial testing placebo group in Skin Condition in 30 participants. Completed in 31 October 2018.
31 July 2018
Quick facts
| Lead sponsor | TCI Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 October 2017 |
| Primary completion | 31 July 2018 |
| Estimated completion | 31 October 2018 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- placebo group
- red djulis drinks
Conditions studied
- Skin Condition — all drugs for Skin Condition →
Sponsor
TCI Co., Ltd. — full company profile →
Who can join
Adults 20 to 65, any sex, with Skin Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypothesis: Using red djulis products can improve skin conditions
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04733859
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Condition
Currently open trials in the same condition.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT06775132 — Associations Between Dietary Intake and Cardiometabolic and Gut Microbiota Outcomes · recruiting
- NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting
- NCT06724627 — Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting · NA · recruiting
- NCT06157567 — Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System · NA · active not recruiting
Other TCI Co., Ltd. trials
Trials by the same sponsor.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT07302828 — Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Vitamin C and Glutathione Liquid Sache · NA · completed
- NCT07172607 — The Effect of Avnace eZZe on Sleep Improvement · NA · recruiting
- NCT07097987 — Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion · NA · not yet recruiting
- NCT07097974 — Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04733859 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TCI Co., Ltd.
- Last refreshed: 2 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04733859.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing